GinkgoPharma(Suzhou)Co.
Latest round
- Series B
Last raised
- Jun 2017
Total raised
- $20M
Investors
- 6
About GinkgoPharma(Suzhou)Co.
, Ltd is a biotechnology company that focuses on the research and development of novel treatments for hepatitis virus.
Who invested in GinkgoPharma(Suzhou)Co.
6 investors across 2 rounds
See all investors in GinkgoPharma(Suzhou)Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GinkgoPharma(Suzhou)Co.
Who invested in GinkgoPharma(Suzhou)Co.?
GinkgoPharma(Suzhou)Co. has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GinkgoPharma(Suzhou)Co. raised?
GinkgoPharma(Suzhou)Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did GinkgoPharma(Suzhou)Co. last raise money?
GinkgoPharma(Suzhou)Co.'s most recent round on record is a Series B, in Jun 2017.
What does GinkgoPharma(Suzhou)Co. do?
, Ltd is a biotechnology company that focuses on the research and development of novel treatments for hepatitis virus.
Where is GinkgoPharma(Suzhou)Co. headquartered?
GinkgoPharma(Suzhou)Co. is headquartered in Suzhou, China.
Which VCs invest in companies like GinkgoPharma(Suzhou)Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at GinkgoPharma(Suzhou)Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like GinkgoPharma(Suzhou)Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.